ESC Premium Access

Questions from the audience and discussion

Session: Hot Line Session 5

Topic: Pharmacotherapy

Event: ESC CONGRESS 2019

Presentation

Become an ESC member to access this resource

Become a member

Already a member? Sign in

12 more presentations in this session

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

3 September 2019 11:00 - 11:12

Speaker: Doctor E. Sorbets (Paris, FR)

Thumbnail

Discussant review - CLARIFY

3 September 2019 11:12 - 11:15

Speaker: Professor D. Hasdai (Petah Tikva, IL)

Thumbnail

Questions from the audience and discussion

3 September 2019 11:15 - 11:18

Thumbnail

SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

3 September 2019 11:18 - 11:30

Speaker: Doctor E. Bjoerklund (Gothenburg, SE)

Thumbnail

Discussant review - SWEDEHEART

3 September 2019 11:30 - 11:33

Speaker: Professor V. Falk (Berlin, DE)

Thumbnail

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study.

3 September 2019 11:36 - 11:48

Speaker: Doctor B. Schrage (Hamburg, DE)

Thumbnail

Discussant review - ICD use in HF

3 September 2019 11:48 - 11:51

Speaker: Professor G. Hindricks (Leipzig, DE)

Thumbnail

Questions from the audience and discussion

3 September 2019 11:51 - 11:54

Thumbnail

PURE - Contrasting patterns of cardiovascular disease, cancers and related mortality between high- versus low-middle income countries in 21 countries

3 September 2019 11:54 - 12:06

Speaker: Doctor D. Leong (Hamilton, CA)

Thumbnail

PURE - Impact of modifiable risk factors on cardiovascular disease and mortality

3 September 2019 12:06 - 12:18

Speaker: Doctor S. Yusuf (Hamilton, CA)

Thumbnail